News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
861,750 Results
Type
Article (87482)
Company Profile (807)
Press Release (773439)
Multimedia
Podcasts (175)
Webinars (28)
Section
Business (233073)
Career Advice (4140)
Deals (39801)
Drug Delivery (138)
Drug Development (91267)
Employer Resources (203)
FDA (18289)
Job Trends (17403)
News (397439)
Policy (39927)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (127)
Alliances (56980)
ALS (147)
Alzheimer's disease (1686)
Antibody-drug conjugate (ADC) (257)
Approvals (18323)
Artificial intelligence (501)
Autoimmune disease (93)
Automation (27)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (163)
Biotechnology (485)
Bladder cancer (136)
Brain cancer (53)
Breast cancer (514)
Cancer (4067)
Cardiovascular disease (352)
Career advice (3560)
Career pathing (38)
CAR-T (250)
CDC (57)
Cell therapy (694)
Cervical cancer (33)
Clinical research (75677)
Collaboration (1419)
Company closure (4)
Compensation (942)
Complete response letters (60)
COVID-19 (2961)
CRISPR (82)
C-suite (609)
Cystic fibrosis (140)
Data (4705)
Decentralized trials (2)
Denatured (63)
Depression (112)
Diabetes (459)
Diagnostics (7099)
Digital health (37)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (239)
Drug pricing (192)
Drug shortages (36)
Duchenne muscular dystrophy (205)
Earnings (98941)
Editorial (54)
Employer branding (25)
Employer resources (172)
Events (133183)
Executive appointments (996)
FDA (20812)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1280)
Gene editing (175)
Generative AI (50)
Gene therapy (555)
GLP-1 (1026)
Government (5387)
Grass and pollen (7)
Guidances (357)
Healthcare (20938)
HIV (48)
Huntington's disease (40)
IgA nephropathy (64)
Immunology and inflammation (245)
Immuno-oncology (21)
Indications (55)
Infectious disease (3210)
Inflammatory bowel disease (191)
Inflation Reduction Act (16)
Influenza (102)
Intellectual property (193)
Interviews (816)
IPO (17928)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (17)
Labor market (80)
Layoffs (641)
Leadership (36)
Legal (10148)
Liver cancer (92)
Longevity (13)
Lung cancer (585)
Lymphoma (268)
Machine learning (31)
Management (66)
Manufacturing (651)
MASH (143)
Medical device (14890)
Medtech (14915)
Mergers & acquisitions (22764)
Metabolic disorders (1171)
Multiple sclerosis (139)
NASH (23)
Neurodegenerative disease (233)
Neuropsychiatric disorders (63)
Neuroscience (2740)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (59)
Obesity (564)
Opinion (315)
Ovarian cancer (137)
Pain (170)
Pancreatic cancer (176)
Parkinson's disease (244)
Partnered (30)
Patents (424)
Patient recruitment (327)
Peanut (57)
People (66312)
Pharmaceutical (145)
Pharmacy benefit managers (27)
Phase I (23343)
Phase II (32844)
Phase III (24760)
Pipeline (2772)
Policy (296)
Postmarket research (3554)
Preclinical (10535)
Press Release (72)
Prostate cancer (204)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (690)
Real estate (7422)
Recruiting (79)
Regulatory (28072)
Reports (65)
Research institute (2693)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (76)
Schizophrenia (138)
Series A (213)
Series B (158)
Service/supplier (30)
Sickle cell disease (81)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (41)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (101)
Tariffs (96)
The Weekly (110)
Vaccines (1057)
Venture capital (67)
Weight loss (399)
Women's health (60)
Worklife (21)
Date
Today (148)
Last 7 days (737)
Last 30 days (2824)
Last 365 days (33553)
2025 (27286)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1280)
Alabama (80)
Alaska (7)
Arizona (307)
Arkansas (14)
Asia (51024)
Australia (8967)
California (9626)
Canada (2895)
China (923)
Colorado (406)
Connecticut (430)
Delaware (276)
Europe (117225)
Florida (1416)
Georgia (318)
Hawaii (3)
Idaho (67)
Illinois (819)
India (54)
Indiana (473)
Iowa (20)
Japan (330)
Kansas (125)
Kentucky (38)
Louisiana (22)
Maine (78)
Maryland (1292)
Massachusetts (7220)
Michigan (317)
Minnesota (570)
Mississippi (4)
Missouri (122)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (79)
New Jersey (2678)
New Mexico (32)
New York (2616)
North Carolina (1424)
North Dakota (10)
Northern California (4390)
Ohio (302)
Oklahoma (22)
Oregon (51)
Pennsylvania (1998)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (50)
South Dakota (1)
Southern California (3671)
Tennessee (150)
Texas (1518)
United States (35516)
Utah (285)
Virginia (250)
Washington D.C. (84)
Washington State (826)
West Virginia (4)
Wisconsin (98)
Wyoming (1)
861,750 Results for "'".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Legend Biotech
Earnings
Novartis CEO Says Trump’s Drug Pricing Deals Don’t Address Root Problem
Vas Narasimhan confirmed that Novartis is having weekly discussions with the Trump administration on drug pricing, but a deal has not yet been reached.
October 28, 2025
·
3 min read
·
Annalee Armstrong
Layoff Tracker
Ferring Will Lay Off 64 Employees in New Jersey
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
October 28, 2025
·
75 min read
·
BioSpace Editorial Staff
Autoimmune disease
BMS, Cabaletta’s CAR T Therapy Spurs Remissions in Small Lupus Trial
Phase I/II data for rese-cel point to its therapeutic potential in systemic lupus erythematosus and lupus nephritis, as well as other autoimmune conditions.
October 28, 2025
·
2 min read
·
Tristan Manalac
Earnings
BioMarin Abandons Gene Therapy Roctavian, Cuts Revenue Guidance as Voxzogo Faces Competitors
BioMarin no longer expects to hit its $4 billion revenue target by 2027, citing various market factors such as impending competition for achondroplasia therapy Voxzogo and the divestment of the gene therapy Roctavian.
October 28, 2025
·
4 min read
·
Tristan Manalac
Autoimmune disease
Biogen Seeks To Stand Out in Lupus With New Anti-CD40L Data
Phase III data for dapirolizumab pegol presented at the 2025 conference of the American College of Rheumatology showed quality-of-life benefits in systemic lupus erythematosus that could see Biogen go head-to-head with GSK and AstraZeneca in a blockbuster space.
October 28, 2025
·
2 min read
·
Tristan Manalac
Press Releases
NeoGenomics Reports Third Quarter 2025 Results
October 28, 2025
·
18 min read
Press Releases
Aldeyra Therapeutics Announces Positive Results from Phase 2 Clinical Trial in Alcohol-Associated Hepatitis, Focuses RASP Product Candidate Pipeline on Next-Generation Molecules
October 28, 2025
·
8 min read
Press Releases
IQVIA Reports Third-Quarter 2025 Results
October 28, 2025
·
19 min read
Press Releases
Natera Reports Strong Advanced Adenoma Data from Prospective PROCEED-CRC Trial, Demonstrating 22.5% Sensitivity and 91.5% Specificity
October 28, 2025
·
4 min read
1 of 86,175
Next
